Omega Therapeutics, Inc. (OMGA)
NASDAQ: OMGA · Real-Time Price · USD
0.790
+0.030 (3.97%)
At close: Nov 20, 2024, 4:00 PM
0.810
+0.020 (2.56%)
Pre-market: Nov 21, 2024, 4:11 AM EST
Omega Therapeutics Market Cap
Omega Therapeutics has a market cap or net worth of $43.58 million as of November 21, 2024. Its market cap has decreased by -56.33% in one year.
Market Cap
43.58M
Enterprise Value
141.34M
1-Year Change
-56.33%
Ranking
Category
Stock Price
$0.79
Market Cap Chart
Since the IPO on July 30, 2021, Omega Therapeutics's market cap has decreased from $792.62M to $43.58M, a decrease of -94.50%. That is a compound annual growth rate of -58.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 43.58M | -73.74% |
| Dec 29, 2023 | 165.98M | -39.50% |
| Dec 30, 2022 | 274.36M | -49.31% |
| Dec 31, 2021 | 541.29M | -31.71% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OS Therapies | 43.02M |
| LAVA Therapeutics | 42.86M |
| Xilio Therapeutics | 42.74M |
| Accelerate Diagnostics | 42.62M |
| Reviva Pharmaceuticals Holdings | 42.47M |
| NeueHealth | 41.51M |
| Nexalin Technology | 41.18M |
| Fortress Biotech | 40.79M |